Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A3JJ
|
||||
| Former ID |
DIB013876
|
||||
| Drug Name |
Pentacea
|
||||
| Synonyms |
HMN14-734; Bispecific CEA antibody (radiotherapeutic pretargeting), IBC; Anti-CEA/anti-In-DTPA antibody, IBC
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Small-cell lung cancer [ICD9: 162.9; ICD10:C33-C34] | Phase 2 | [547157] | ||
| Company |
IBC Pharmaceuticals Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Carcinoembryonic antigen-related cell adhesion molecule 5 | Target Info | [544124] | ||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.